September 2025 Newsletter - FUJIFILM Biotechnologies

September 2025 Newsletter FUJIFILM Biotechnologies is proud to be an innovative CDMO partner, seamlessly guiding our customers though their journey of creating life-impacting medicines from initial process development stages through to full commercial supply. Catch up on our latest news and insights below.

Celebrating an Exciting New Chapter!

FUJIFILM Biotechnologies celebrated the grand opening of our new state-of-the-art biopharmaceutical manufacturing hub in Holly Springs, North Carolina on September 24th.

Following a total investment of over $3.2 billion, the site adds significant large-scale production capacity to our global network.
The new facility provides 8 x 20,000 L mammalian cell culture bioreactors for large-scale cell culture manufacturing of bulk drug substance and flexible Drug Product and Finished Goods facility for multiple vial and prefilled syringe formats.
A further 8 x 20,000 L bioreactors are scheduled to come online by 2028, making this one of the largest cell culture biomanufacturing facilities in North America.

Through our modular operational model, kojoX™, the company has been able to construct nearly identical large-scale production facilities in the US and Denmark to ensure that customers can seamlessly integrate manufacturing production regardless of location. Click below to watch a virtual tour of Holly Springs.

Virtual Tour ›

SOLUTIONS SPOTLIGHT Mammalian Cell Culture

Learn how we are building scalable cell culture manufacturing solutions through our kojoX ™ ecosystem Download the white paper →	Looking to develop or optimize your process? Explore our process development services Learn More→	Need to improve your efficiencies and solve technical challenges? Discover MaruX™ continuous manufacturing →

NOW TRENDING

In the News

The new FUJIFILM Biotechnologies facility in Holly Springs has several customers ready to start manufacturing as soon as the doors are open and the facility is fully qualified. Learn more about the public announcements from Regeneron, Johnson & Johnson, and argenx.
As the cell and gene therapy landscape continues to evolve, Jonathan Haigh, UK Site Head, sat down with Pharma’s Almanac as part of a panel discussion on the biggest roadblocks still standing in the way of cell and gene therapy commercialization. Read more →
We have recently welcomed Dr. Samuel Hernandez as the new site head at our facility in College Station, Texas. He has over two decades of experience in biotechnology and pharmaceutical leadership and will now lead our 700+ strong team at the site, which provides development and manufacturing services for cell culture and advanced therapies. Read the press release →
As CPHI quickly approaches, organizers sat down with UK Site Head, Jonathan Haigh, to discuss critical trends affecting the industry. In this exclusive interview, Jonathan delves into the promising innovations and emerging technologies shaping the future of biologics and advanced therapies. Learn more →

Upcoming Events

	Festival of Biologics September 30 – October 2 \| Basel \| Booth #651 Charlie Heise, Associate Director, Bioprocessing Strategy & Development, will be presenting on the topic: “KojoX – A Transformative Operational Ecosystem Delivering Flexible Manufacturing Strategies and Security of Supply” on September 30. Learn More →

	Cell & Gene Meeting on the Mesa October 6 – 8 \| Phoenix, AZ \| Booth #F28 FUJIFILM Biotechnologies is holding an exclusive networking event on Tuesday, October 7, at the Arizona Biltmore Hotel. This is a chance to strengthen connections and explore opportunities for collaboration. Tickets are free and available on a first come, first served basis, so sign up today! Learn More →

CPHI 2025

October 28 – 30 | Frankfurt | Booth #4.1J8

Jonathan Haigh, UK Site Head, will be speaking on the following topic Wednesday, October 29 at 2:45 in the Next-Gen Bio Theatre: Leveraging Continuous Biomanufacturing Within a kojoX™ Ecosystem for Improved Accessibility to Complex Biotherapeutics.

Christian Houborg, General Manager & SVP of FUJIFILM Biotechnologies, and Yannic Werner, EMEA Manager of Pharmaceutical & Microbiological Quality Control at FUJIFILM Wako Chemicals, will join a panel on: Redefining Bio-Manufacturing for a Faster, Sustainable Future. Join us in the Next-Gen Bio Theatre on Wednesday, October 29 at 11:35.

Learn More →

Update Your Email Preferences Want to keep up to date with all the news and service offerings from FUJIFILM Biotechnologies? Let us know more about the information you’re interested in receiving from us by using the link below. Update My Preferences ›

Visit our website:

https://fujifilmbiotechnologies.fujifilm.com/